Low-Dose Cyclophosphamide Associated With Hyponatremia and Hepatotoxicity

Cyclophosphamide (CY) is an alkylating agent often used as a chemotherapeutic agent, with increasing use as an immunosuppressant. Cyclophosphamide has many established adverse effects, including hyponatremia and limited reports of hepatotoxicity, particularly in high-dose treatment. A case of simult...

Descripción completa

Detalles Bibliográficos
Autores principales: DeChiara, James R, Birch, Eleanor M, Harper, Hillary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578966/
https://www.ncbi.nlm.nih.gov/pubmed/37849582
http://dx.doi.org/10.7759/cureus.45375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578966/
https://www.ncbi.nlm.nih.gov/pubmed/37849582
http://dx.doi.org/10.7759/cureus.45375

Ejemplares similares